Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

17:12 Navan to file confidentially for IPO, betting on market reopening

More stories in CTech

MeMed

15 stories about MeMed

Med-Tech Israeli startups and how they truly impact patients’ lives
31.03.22|Efrat Hartog-David“Israel enjoys global prominence in the Med-Tech sector, even though it’s a tiny country. Its strength lies in the unique cultural DNA within each individual and within each team,” writes Efrat Hartog-David of MeMed
MeMed raises $93 million to translate the immune system
10.01.22|Meir OrbachThe Israeli company recently received FDA approval for its MeMed BV test to help healthcare providers distinguish between bacterial and viral infections
MeMed’s Covid-19 severity test receives its CE Mark to predict severe outcomes
27.07.21|James SpiroThe 15-minute test runs on the company’s point-of-need platform, MeMed Key
MeMed’s Leadership classes came in handy during Covid-19
01.03.21|CTechDuring the pandemic, managers were faced with unprecedented new challenges. The Biotech company decided to do something about it
Women represent an untapped pool of scientific talent, what we need is more role models
11.02.21|Mary Hainrichson In honor of the International Day of Women and Girls in Science, MeMed’s Dr. Mary Hainrichson offers some words of encouragement
MeMed analyzes complex immune responses to answer simple health questions
26.10.20|Yafit OvadiaGrowing biotechnology company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers
Which UAE-based company is bidding $50 million for an Israeli airline and why are patents so important?
25.10.20|CTechCTech Daily Roundup: Israeli high tech delegation departs for the Emirates in search of collaborations
Italian biotech company DiaSorin to offer MeMed’s blood tests in Europe and USA
08.09.20|Hagar RavetHaifa-based MeMed develops blood testing technology capable of diagnosing whether an infection is bacterial or viral, based on the presence of specific proteins in the blood
Which Israeli Startup Sold for $365 Million and Who is the Billionaire that Fell Victim to a Real Estate Sting?
02.06.20|CTechCTech Daily Roundup: National Instruments acquires Israel-Based data analytics startup OptimalPlus for $365 million
MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions
02.06.20|Omer Kabir Israel-based company tests the immune system’s reaction to infection rather than the infection itself
Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering
20.09.18|Omer KabirThe company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers
Viral-Bacterial Blood Test Company MeMed Gets Comparative Vote of Confidence
17.05.18|Omer KabirA study by Israeli medical researchers compared the company’s automated test to similar ones and found it has the potential to reduce antibiotic overuse by almost 90%
CTech’s Daily Israeli Tech News Roundup
07.02.18|CTechAlibaba partners with Israeli startup to supply a cloud database in China. Black Cube, of Weinstein affair infamy, moves into larger, fancier headquarters.
Bacteria or Virus? Automated Blood Tests Startup MeMed Wins Department of Defense Grant
07.02.18|Omer KabirMeMed develops a printer-sized automated blood test device that can diagnose the source of infections in under 15 minutes, compared to days-long lab tests
Automated Medical Diagnosis Startup Raises $30 Million
19.09.17|Omer KabirIsrael-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense

About CTech Terms of Use Privacy Policy

Back to Top